Document Detail

Management and prevention of exacerbations of COPD.
MedLine Citation:
PMID:  25245156     Owner:  NLM     Status:  Publisher    
Patients with chronic obstructive pulmonary disease (COPD) are prone to acute respiratory exacerbations, which can develop suddenly or subacutely over the course of several days. Exacerbations have a detrimental effect on patients' health status and increase the burden on the healthcare system. Initial treatment is unsuccessful in 24-27% of patients, who have a relapse or a second exacerbation within 30 days of the initial event. No obvious benefit has been seen in recent clinical trials of anti-tumour necrosis factor therapy, anti-leukotriene therapy, intensive chest physiotherapy, or early inpatient pulmonary rehabilitation for treatment of exacerbations. By contrast, clinical trials of prevention rather than acute treatment have shown promising results. Long acting β agonist (LABA) or long acting anti-muscarinic (LAMA) bronchodilators and inhaled corticosteroid-LABA combinations prevent exacerbations in patients at risk, with relative risk reductions averaging 14-27% for each of these drugs relative to placebo. Triple therapy with inhaled corticosteroid-LABA plus LAMA may provide additional benefit, although study results to date are heterogeneous and more studies are needed. Pneumonia is an important complication of treatment with inhaled corticosteroid-LABA products, and the risk of pneumonia seems to be doubled in patients with COPD who use fluticasone. The addition of azithromycin to usual COPD therapy prevents exacerbations, although it may prolong the Q-T interval and increase the risk of death from cardiovascular disease in patients prone to arrhythmia. New potential drugs-including mitogen activated protein kinase inhibitors, phosphodiesterase 3 inhibitors, and monoclonal antibodies to the interleukin 1 receptor-offer additional hope for treatments that may prevent exacerbations in the future.
Shawn D Aaron
Related Documents :
22394606 - Clinical characteristics and patterns of healthcare utilization in patients with painfu...
3007576 - Stimulation of gonadal steroid synthesis by chronic excess of adrenocorticotropin in pa...
25160616 - The epidemiology of dysphonia in the aging population.
16917406 - Severe muscular weakness: an unusual adverse effect of azathioprine therapy.
23402766 - Identifying a predictive model for response to atypical antipsychotic monotherapy treat...
7226576 - Prevalence of various degrees of hypothyroidism among patients of a general medical dep...
Publication Detail:
Type:  REVIEW     Date:  2014-9-22
Journal Detail:
Title:  BMJ (Clinical research ed.)     Volume:  349     ISSN:  1756-1833     ISO Abbreviation:  BMJ     Publication Date:  2014  
Date Detail:
Created Date:  2014-9-23     Completed Date:  -     Revised Date:  2014-9-24    
Medline Journal Info:
Nlm Unique ID:  8900488     Medline TA:  BMJ     Country:  -    
Other Details:
Languages:  ENG     Pagination:  g5237     Citation Subset:  -    
Copyright Information:
© BMJ Publishing Group Ltd 2014.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Sexual assault in Lagos, Nigeria: a five year retrospective review.
Next Document:  17?-estradiol rapidly facilitates lordosis through G protein-coupled estrogen receptor 1 (GPER) via ...